Literature DB >> 29800027

An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.

Ameet Sarpatwari1, Jerry Avorn1, Aaron S Kesselheim1.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29800027     DOI: 10.1001/jama.2018.7424

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.

Authors:  Chana A Sacks; ChangWon C Lee; Aaron S Kesselheim; Jerry Avorn
Journal:  JAMA       Date:  2018-08-21       Impact factor: 56.272

2.  Generic Drugs in the United States: Policies to Address Pricing and Competition.

Authors:  Ravi Gupta; Nilay D Shah; Joseph S Ross
Journal:  Clin Pharmacol Ther       Date:  2019-01-10       Impact factor: 6.875

3.  Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study.

Authors:  Michael Liu; Brian MacKenna; William B Feldman; Alex J Walker; Jerry Avorn; Aaron S Kesselheim; Ben Goldacre
Journal:  J R Soc Med       Date:  2020-09       Impact factor: 5.344

4.  Rational Prescription and Cost-Effective Medication: Challenges and Opportunities in Pakistan.

Authors:  Fahmida Aslam; Faiz Ullah Khan; Yang Yue
Journal:  Innov Pharm       Date:  2020-10-22

5.  Competition and price among brand-name drugs in the same class: A systematic review of the evidence.

Authors:  Ameet Sarpatwari; Jonathan DiBello; Marie Zakarian; Mehdi Najafzadeh; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2019-07-30       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.